AzTrials
AzTrials

Genetic Predisposition to DiseaseNCT06193005

Correlation Between Psychological Resilience and Genetic, Inflammatory Indicators

An observational study of Genetic Predisposition to Disease and Environment, run by Qianfoshan Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to evaluate and analyze the influencing factors of the adaptive ability of young people, explore the impact of the interaction of environment and gene on the psychological adaptive ability of young people, incorporate the prediction model of the dynamic change of adaptive… Read more about this study

Who is it for?
Ages 18 to 24 yearsHealthy volunteers can take part
How many people
400 participants
Where
No sites listed yet
Study dates
1 Jan 2024to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: 18-24 years old young people

Who may be able to join

  • Age 18-24 years old; high school graduation and above; agree to collect blood samples and sign an informed consent form.

Who cannot join

  • Did not consent to the collection of blood samples; did not sign an informed consent form; suffered from a major illness such as a malignant tumor.

Trial locations and contacts

No sites are listed yet.

Wenqi Hu, MPH contact

15098719908

huwenqi_epi@163.com

About this study

Official title: A Study of the Correlation Between Psychological Resilience and Genetic, Inflammatory Indicators in Young Population

The goal of this observational study is to evaluate and analyze the influencing factors of the adaptive ability of young people, explore the impact of the interaction of environment and gene on the psychological adaptive ability of young people, incorporate the prediction model of the dynamic change of adaptive ability, build a standardized norm of young people's adaptive ability, and form a grading reference standard system. The main questions it aims to answer are:

  • What are most important influencing factors for the adaptive ability of young people?
  • How the environment and gene interact with each other on the psychological adaptive ability of young people?
  • Can we build a prediction model of the dynamic change of adaptive ability and form a grading reference standard system?

Participants will support us with basic information data, adaptive ability assessment data, genetic testing data, brain image scanning data, and inflammatory indicators data. Then subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score. And the statistical analysis will be performed by the data analyst.

Read the detailed description

18-24 years old is an important stage of psychological development and personality shaping of young people. The higher cortex of the brain, which is responsible for emotional regulation and environmental coping, enters a critical period of neuroplasticity development. Its psychological development is characterized by transition, closure and turbulence, etc. When facing the stressful environment such as college entrance, employment and rapid social development, depression, anxiety and other negative emotional experiences may occur. All kinds of psychological problems. According to the critical period theory of emotional development, emotional states and stress coping are regulated by the activities of the brain's higher cortex. At the same time, the occurrence of mental disorders such as adaptation disorders is also influenced by genetics, and people with high-risk genes are more likely to have disorders.

The purpose of this study is to focus on the evaluation and analysis of the influencing factors of the adaptive ability of young people, explore the impact of the interaction of environment and gene on the psychological adaptive ability of young people, incorporate the prediction model of the dynamic change of adaptive ability, build a standardized norm of young people's adaptive ability, and form a grading reference standard system.

Research contents: 1) According to the cognitive theory system of adaptive ability and the individual prediction model of adaptive ability, considering the environmental characteristics that affect the adaptive ability of young people, the evaluation items with high predictive power of the model are screened. 2) Test the adaptive ability evaluation system in the research objects, verify the reliability, validity and extensibility of the task, and verify the measurement reliability and ecological validity of the paradigm tool. 3) Representative populations with high and low adaptive ability were selected to conduct multi-dimensional data collection on genetics and brain nerve, study the genetic risk and risk gene loci of adaptive ability, analyze the brain image features corresponding to adaptive ability, and study the neural mechanism of adaptive ability.

This study was designed as a cross-sectional study, with young people aged 18-22 as the research objects. The inclusion criteria included 18-22 years old, high school graduation or above, consent to blood sample collection, and signed informed consent. Exclusion criteria include not agreeing to take blood samples, not signing informed consent forms, and having a major medical condition such as a malignant tumor. It is planned to recruit 400 subjects from January 1, 2024 to March 31, 2024, and collect basic information data, adaptive ability assessment data, genetic testing data, brain image scanning data, and inflammatory indicators data.

The subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score. A variety of predictive modeling techniques (such as Logistic discriminant model, neural network model, decision tree, random forest model and support vector machine, etc.) are used to construct a dynamic change prediction model adapted to outcome risk. The internal validation of the model was carried out by using the ten-fold cross-validation method. The original data were divided into 10 groups, among which 9 groups were taken as the training set and 1 group was taken as the test set for cross-validation to ensure the stability of the model. ROC curve was drawn to evaluate the differentiation of evaluation models. The area under ROC curve synthesizes two indexes of sensitivity and specificity, and considers every possible threshold value, which can evaluate the diagnostic value of the model more objectively and accurately. By calculating the area AUC under ROC curve as a quantitative analysis of the diagnostic value of the model, the closer the AUC is to 1, the better the diagnostic effect is. The Hosmer-Lemeshow goodness of fit test was used to judge the degree of consistency between the predicted risk and the actual risk, so as to evaluate the calibration degree of the model.

Being tested
no intervention
Medical subject headings
Genetic Predisposition to Disease, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no interventionOther

    no intervention

Study groups in NCT06193005
Study groupRoleWhat they receive
very low adaptive groupThe subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.
Receives: Other: no intervention
low adaptive groupThe subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.
Receives: Other: no intervention
high adaptive groupThe subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.
Receives: Other: no intervention
very high adaptive groupThe subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.
Receives: Other: no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the Assessment of the Psychological Resillience

    Psychological Resillience was evaluated across multiple dimensions, including cognitive functioning, stress coping, psychological well-being, and personality traits, and was measured using internationally accepted scales. Psychological Resillience is measured using the Psychological Resilience Scale (CD-RISC), which consists of 25 items rated on a 5-point Richter's scale, with scores ranging from 0 to 4 indicating that this is not the case at all, seldom the case, sometimes the case, often the case, and almost always the case. The sum of the scores of the items is the total score of the scale, and the total score is 0~100, the larger the score indicates the higher the level of psychological resilience, and the score of less than 60 is the poor level of psychological resilience, 61~69 is the average level of psychological resilience, 70~79 is the good level of psychological resilience, and >=80 is the excellent level of psychological resilience.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2024
  2. Study start1 Jan 2024 (estimated)
  3. Primary completion31 Mar 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06193005
Sponsor's protocol ID
SDHMC-231202
Status last verified
Dec 2023
First submitted
11 Dec 2023
Last updated
5 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is not a plan to make IPD available.

Publications

  • Greenberg RL, Guzick AG, Schneider SC, Weinzimmer SA, Kook M, Perozo Garcia AB, Storch EA. Depressive Symptoms in Autistic Youth with Anxiety Disorders. J Dev Behav Pediatr. 2023 Dec 1;44(9):e597-e603. doi: 10.1097/DBP.0000000000001223. Epub 2023 Oct 11.

    PubMed 38019467
  • Brunette MF, Erlich MD, Edwards ML, Adler DA, Berlant J, Dixon L, First MB, Oslin DW, Siris SG, Talley RM. Addressing the Increasing Mental Health Distress and Mental Illness Among Young Adults in the United States. J Nerv Ment Dis. 2023 Dec 1;211(12):961-967. doi: 10.1097/NMD.0000000000001734.

    PubMed 38015186
  • Wong WLE, Arathimos R, Lewis CM, Young AH, Dawe GS. Investigating the role of the relaxin-3/RXFP3 system in neuropsychiatric disorders and metabolic phenotypes: A candidate gene approach. PLoS One. 2023 Nov 15;18(11):e0294045. doi: 10.1371/journal.pone.0294045. eCollection 2023.

    PubMed 37967073

Questions about this trial

What is this clinical trial studying?

An observational study of Genetic Predisposition to Disease and Environment, run by Qianfoshan Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wenqi Hu, MPH (15098719908, huwenqi_epi@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the Assessment of the Psychological Resillience (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06193005, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in